hit counter

Peripheral Inflammatory Biomarkers vs. Suicide Risk in Major Depression (2024 Study)

Major Depressive Disorder (MDD) is not just a mental health concern; it’s a complex interplay of psychological, environmental, and biological factors, where the most tragic outcome can be suicide. Recent research has unveiled a potential link between the immune system’s inflammatory response and the increased risk of suicide among those suffering from MDD. By examining …

Read more

Sleep Disorders vs. Systemic Immune-Inflammation Index (SII) in the U.S. Population (2023 Study)

Sleep and inflammation have long been topics of scientific inquiry, with a growing body of evidence underscoring their intricate relationship. The systemic immune-inflammation index (SII), a novel marker based on leukocyte parameters, has emerged as a significant indicator of systemic inflammation. A recent study explored the association between sleep-related disorders and SII, revealing intriguing connections …

Read more

Abnormal Brain EEG Activity Doesn’t Predict Antidepressant Efficacy in Depression (2023 Study)

Depression is a multifaceted mental health condition that presents significant challenges in both diagnosis and treatment. Recent studies have explored the potential of electroencephalography (EEG) as a predictive tool for treatment outcomes in major depressive disorder (MDD), with particular focus on the response to antidepressants like escitalopram. Highlights: EEG Abnormalities & Antidepressant Response: Contrary to …

Read more

Plasma Metabolomics as Biomarkers in Depression: Betaine & Piperine Abnormalities (2024 Study)

Depression is a complex mental health disorder that affects millions worldwide, presenting a significant challenge to both diagnosis and treatment. Recent advances in metabolomics—the study of small molecules in biological systems—have opened new avenues for understanding the biochemical underpinnings of depressive disorders. By analyzing blood serum metabolites, researchers can now identify biomarkers that distinguish patients …

Read more

Brain Biomarkers in Suicide Attempts: Elevated 5-HT1A Heteroreceptors & Hyperactivity in Superior Temporal Gyrus (2023 Review)

Suicide, a tragic end to around 800,000 lives each year, remains one of the most perplexing and devastating phenomena in mental health. Despite the vast number of studies and data, accurately predicting who is at risk of suicide has remained largely elusive, with current tools heavily reliant on subjective assessments and the clinician’s experience. A …

Read more

Abnormal Glutamate Biomarkers in ADHD: CDK5, MAP2, GKAP, PSD95 (2023 Study)

Attention-Deficit Hyperactivity Disorder (ADHD) is a complex neurodevelopmental condition that has puzzled researchers and clinicians for decades. Recent studies have begun to unravel the intricate relationship between ADHD and the glutamatergic system, a major neurotransmitter pathway in the brain. A newer study evaluated the roles of cyclin-dependent kinase 5 (CDK5), microtubule-associated protein-2 (MAP2), guanylate kinase-associated …

Read more

Symptom Provocation in Psychiatric Disorders: TMS, EEG, Neural Circuits for Personalized Treatment (2023 Review)

Symptom provocation, a cornerstone of psychiatric research and therapy, offers a fascinating glimpse into the intricate relationship between brain activity and psychiatric symptoms. By deliberately triggering symptoms, researchers and clinicians can identify neurophysiological biomarkers and target them with personalized therapies, such as transcranial magnetic stimulation (TMS). This technique not only enhances our understanding of psychiatric …

Read more